Work

An Open-Label, Multicenter, Phase Ib Study of the Anti-TIM3 Monoclonal Antibody BC3402 in Combination with Azacitidine in Patients with Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-201319

Authors: Bing Li, Qing-song Yin, Xiaojing Yan, Min Hang, Hai-Jun Guo, Sheng Wang, Yi-wei Wang, Yong-jiang Hei, Zhi-jian Xiao

Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, Zhengzhou University, First Hospital of China Medical University, Wuxi Municipal Bureau on Science and Technology, Wuxi Wind Power Design and Research Institute

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405038944

Cites:

Cited by:

Related to: 10